Derivation Web

claim_d0d5601705884e25

{"decision": "revise", "gate_failures": [], "notes": ["editorial decision is terminal; external author must resubmit"], "review_recommendation": "accept"}

source_b712c37fda274c52

# Research Synthesis: Metformin Treatment Effects — full paper

## Abstract

Evidence scope: 18/33 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Metformin remains the first-line glucose-lowering agent for type 2 diabetes, and the breadth of its pur…